PreCOG, LLC is dedicated to advancing cancer research across all phases of clinical trials, focusing on innovative methodologies and collaborative efforts with physician research leaders and industry partners. The organization aims to design, implement, and publish clinical trial results that address the evolving needs of cancer patients and enhance the understanding of cancer diseases. Established in 2006 as a not-for-profit entity, PreCOG operates independently from the public health system and is governed by a Board of Managers that oversees its clinical trial activities. The organization is committed to supporting the ECOG-ACRIN Cancer Research Group's mission to improve cancer care, reduce the burden of the disease, and enhance patient quality of life and survival rates.

PreCOG's operational framework is built on adherence to Standard Operating Procedures that comply with FDA regulations and ICH/GCP guidelines, ensuring the integrity and reliability of its research. While PreCOG typically serves as the regulatory sponsor for its clinical trials, it also engages in collaborative research efforts with other cancer research groups and industry partners, allowing for shared expertise and responsibilities. This collaborative approach not only fosters innovation in cancer research but also aims to provide new hope for patients and their families through the development of effective treatment strategies.

United States

We are a multidisciplinary membership-based scientific organization that designs and conducts biomarker-driven cancer research involving adults who have or are at risk of developing cancer

PreCOG

Company Details